Wei-xia Nong
Nanning, 530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
OY-TES-1 Splice Variant V5a in Glioma: A Driver of Malignancy and Potential Therapeutic Target.
Journal: Current medical science
Published: October 22, 2025
Cancer-testis antigen ACRBP: Cytotoxic response to its HLA-A2 restricted peptide and immune features in ovarian cancer.
Journal: Human vaccines & immunotherapeutics
Published: October 16, 2025
Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23.
Journal: Human vaccines & immunotherapeutics
Published: December 15, 2023
Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma.
Journal: Frontiers in oncology
Published: February 11, 2022
High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma.
Journal: Current medical science
Published: February 11, 2022
Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
Journal: Current medical science
Published: November 14, 2021
FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy.
Journal: Current medical science
Published: March 30, 2021
Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma.
Journal: American journal of translational research
Published: August 15, 2020
Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
Journal: Current medical science
Published: July 17, 2019
Histone deacetylase 5 promotes the proliferation of glioma cells by upregulation of Notch 1.
Journal: Molecular medicine reports
Published: November 17, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026